0001415889-22-012300.txt : 20221209
0001415889-22-012300.hdr.sgml : 20221209
20221209160608
ACCESSION NUMBER: 0001415889-22-012300
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221208
FILED AS OF DATE: 20221209
DATE AS OF CHANGE: 20221209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHABER CHRISTOPHER J
CENTRAL INDEX KEY: 0001068029
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14778
FILM NUMBER: 221454817
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER NAME:
FORMER CONFORMED NAME: SCHABER CHRISTOPHER
DATE OF NAME CHANGE: 19980811
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLIGENIX, INC.
CENTRAL INDEX KEY: 0000812796
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 411505029
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE B-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-538-8200
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE B-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DOR BIOPHARMA INC
DATE OF NAME CHANGE: 20020329
FORMER COMPANY:
FORMER CONFORMED NAME: ENDOREX CORP
DATE OF NAME CHANGE: 19960916
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19920703
4
1
form4-12092022_091249.xml
X0306
4
2022-12-08
0000812796
SOLIGENIX, INC.
SNGX
0001068029
SCHABER CHRISTOPHER J
C/O SOLIGENIX, INC.
29 EMMONS DRIVE, SUITE B-10
PRINCETON
NJ
08540
true
true
false
false
CHAIRMAN, CEO AND PRESIDENT
Option (Right to Buy)
0.54
2022-12-08
4
A
0
140000
0
A
2022-12-08
2032-12-07
Common Stock
140000
140000
D
The stock option vested immediately as to 35,000 shares and vests as to the remainder at a rate of 8,750 of the shares on each three (3) month anniversary of December 8, 2022.
/s/ Christopher J. Schaber
2022-12-09